Abstract 5842: Combined KRAS pathway inhibition and ONIOYID treatment enhances tumor regression, attenuates desmoplasia, and augments T cell infiltration in pancreatic ductal adenocarcinoma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Mayo Clinic in Florida
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148844805
Cites:
Cited by:
Related to: